S384-0475 Screening compound: N~3~-(2,3-dihydro-1H-inden-5-yl)-6-(4-fluorophenyl)-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazine-3-carboxamide

S384-0475 Screening compound: N~3~-(2,3-dihydro-1H-inden-5-yl)-6-(4-fluorophenyl)-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazine-3-carboxamide
S384-0475 Screening compound: N~3~-(2,3-dihydro-1H-inden-5-yl)-6-(4-fluorophenyl)-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S384-0475
N~3~-(2,3-dihydro-1H-inden-5-yl)-6-(4-fluorophenyl)-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S384-0475

Molecular Formula

C21H19FN4O2 (C21 H19 FN4 O2)

Compound Name

N~3~-(2,3-dihydro-1H-inden-5-yl)-6-(4-fluorophenyl)-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazine-3-carboxamide

IUPAC name

N-(23-dihydro-1H-inden-5-yl)-6-(4-fluorophenyl)-4H6H7H-[123]triazolo[43-c][14]oxazine-3-carboxamide

SMILES

O=C(c1c(COC(C2)c(cc3)ccc3F)n2nn1)Nc1cc(CCC2)c2cc1

InChI

InChI=1S/C21H19FN4O2/c22-16-7-4-14(5-8-16)19-11-26-18(12-28-19)20(24-25-26)21(27)23-17-9-6-13-2-1-3-15(13)10-17/h4-10,19H,1-3,11-12H2,(H,23,27)/t19-/m0/s1

InChI Key

IIEANBVTCQUXEI-IBGZPJMESA-N

MDL Number (MFCD)

MFCD29032900

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

378.41

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.218

Distribution Coefficient, logD

3.218

Water Solubility, LogSw

-3.31

Polar Surface Area

58.137

Acid Dissociation Constant (pKa)

10.90

Base Dissociation Constant (pKb)

-1.25

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

28.57

S384-0475 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

New Agro Library (44492 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Eye
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Ion Channels
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
  • Cyclic compounds
Agro:
  • Agro

References: we are preparing a list of scientific research reports with S384-0475 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S384-0475?
Check Price and Availability of S384-0475, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S384-0475 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S384-0475
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S384-0475
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S384-0475 available by request